Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Clinicopathologic Conference, Creutzfeldt-Jakob Disease
NEJM 381:1569-1578, Case 32-2019, 2019
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011
Tissue Distribution of Bovine Spongiform Encephalopathy Agent in Primates after Intravenous or Oral Infection
Lancet 363:422-428,411, Herzog,C.,et al, 2004
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
Bovine Spongiform Encephalopathy in the United States - An Epidemiologist's View
NEJM 350:539-542, Donnelly,C.A., 2004
Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004
Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004
The Pulvinar Sign on Magnetic Resonance Imaging in Variant Creutzfeldt-Jakob Disease
Lancet 355:1412-1418,1384, Zeidler,M.,et al, 2000
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
Transmissible Spongiform Encephalopathies
NEJM 337:1821-1828, Haywood,A.M., 1997
Potential Transmission of BSE via Medicinal products
BMJ 312:988-989, Wickham,E.A., 1996